A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
Clinical trial NCT05246033 · COMPLETED
Trial details
- NCT number
- NCT05246033
- Sponsor
- Visen Pharmaceuticals (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2023-03-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.